Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Innovative ideas from across the Oxford University Hospital Trust have received expert support in a bid to help them realise their patient potential.

Four projects have been supported by the inaugural OUH Innovation Challenge ranging from a novel walking aid design to a new biomaterial to repair soft tissue.

Trust non-executive director Chris Goard, who chaired the assessment panel, said: “Innovation is at the heart of improving healthcare and is a key strength of Oxford University Hospitals. All our staff play a vital role in delivering care and it is their expertise and experience that gives rise to brilliant ideas. This competition, open to everyone, is about tapping into that and giving great ideas the support they need to get to next level.  Ultimately, it is ideas like these that will benefit patients and clinical teams. The innovation we saw from across the Trust was outstanding.

The competition was open to all OUH staff and is part of OUH’s drive to increase awareness of innovation and to build links with industrial partners.  The aim was to develop solutions for unmet medical needs and to improve the OUH services for patients. 

All ideas are eligible for support and can include medical devices, diagnostic tools, computer software, guidelines or training packages, or questionnaires quantifying patient outcomes. The ideas must be able to be developed with an industry partner.

Supported projects in the 2014 Challenge were:

  • An acute referrals system to document and manage acute, specialist referrals between different healthcare organisations (Nick de Pennington, Specialist Registrar, Neurosurgery; Lauren Morgan, Human Factors Research Scientist)
  • Nanofibrous yarns - low cost fabrication of a new generation of implantable medical fibres to stimulate repair of soft tissue (Pierre-Alexis Mouthuy, Post Doc Researcher ; Andrew Carr, Orthopaedic Surgeon, NOC)
  •  An innovative walking aid device (Simon Wood, Senior Physiotherapist, NOC)
  • A knee stress x-ray device (Thomas Hamilton, Clinical Research Fellow, NOC)

The teams will now be given support to progress their ideas to the next stage. The competition provides financial support and mentoring.

Shortlisted entries were assessed by a panel including Mr Goard, Nick Edwards (Oxford Academic Health Science Network), Dr Ian Reckless (OUH Clinical Director, Neurosciences), Glenn Wells (OUH Associate Director of Research and Development) and Victoria Bates (Customer Operations Director, Pfizer) The competition is set to run again in 2015 for more information contact Cynthia Ugochukwu via email Cynthia.ugochukwu@ouh.nhs.uk

Oxford University Hospital Trust 

Similar stories

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Oxford expands the Cartography collaboration with Janssen

The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation

Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology

The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.

Oxford University retains top spot for spinout generation in the UK

Oxford University has been ranked first in the UK for turning academic research into spinout companies, according to a new report published today by data analyst firm Beauhurst.

The glass half full man: Professor Chas Bountra and Oxford's innovative future

Forget the TV clichés about Oxford – all punting and pass the port. The 925-year-old university is full of the most amazing people who are helping and benefiting the world, well beyond the quads and spires, says Professor Chas Bountra, the university’s Pro-Vice-Chancellor for Innovation. After the events of the last two years - and the COVID-19 vaccine [2.5 billion doses delivered and counting] - this most enthusiastic champion of Oxford maintains there can be no doubt, innovation is part and parcel of the historic university’s future. Who knows what is coming next, he says, expectantly.

Exscientia and University of Oxford launch “Xcellomics” program to expedite early-stage academic research and translate novel biology into future drug discovery

Exscientia and the University of Oxford's Target Discovery Institute (TDI) today announced the formation of Xcellomics – a program designed to source cellular functional assays from the global academic community to develop novel screens and identify targets and therapeutic candidates for unmet medical needs.